ArnaudBastienMD

PubMed

• Mavacamten: Real-World Experience from 22 Months of the Risk Evaluation and Mitigation Strategy (REMS) Program.
  Milind Y Desai, Dewey Seto, Michael Cheung, Sonia Afsari, Niki Patel
  Circulation. Heart Failure. 2024-11-11
• Diverse Concepts in Definitions of Dilated Cardiomyopathy: Theory and Practice.
  Michael C Myers, Boris Breznen, Yue Zhong, Sonomi Maruyama, Cindy Bueno
  Cardiology Research. 2024-10-01
• Prevalence of Genetically Associated Dilated Cardiomyopathy: A Systematic Literature Review and Meta-Analysis.
  Michael C Myers, Su Wang, Yue Zhong, Sonomi Maruyama, Cindy Bueno
  Cardiology Research. 2024-08-01

Journal Articles

• Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with Type 2 diabetes mellitus  
  Gerich John E; Bastien Arnaud, Expert Review of Clinical Pharmacology, 1/1/2011
• A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers  
  John P.H. Wilding, MD; Paul Norwood, MD; Caroline T’Joen, MSC; Arnaud Bastien, MD; James F List, MD PHD; Fred T. Fiedorek, MD, Diabetes Care, 1/1/2009
• Management of High Blood Pressure in Clinical Practice: Perceptible Qualitative Differences in Approaches Utilized by Clinicians  
  Nwachuku, Bastien, Cutler, Grob, Margolis, Rocella, Pressel, Davis, Caso, Sheps, and Weber J, Clinical Hypertension, 1/1/2008
• Blood Pressure Control by Drug Group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)  
  William C. Cushman, MD ; Charles E. Ford, PhD; Paula T. Einhorn, MD, MS ; Jackson T. Wright Jr, MD, PhD; Richard A. Preston, MD; Barry R. Davis, MD, PhD; Jan N. Basi..., Clinical Hypertension, 1/1/2008
• Health-Related Quality of Life and Cost-Effectiveness Components of the Action to control Cardiovascular Risk in Diabetes (ACCORD) Trial: Rationale and Design  
  Mark D. Sullivan MD, PhD, Roger T Anderson PHD, David Aron MD MS, Hal Atkinson MD, Arnaud Bastien MD, John Chen MD PhD et al, J.AmJCard, 1/18/2007
• Recruitment Strategies in the Action to control Cardiovascular Risk in Diabetes (ACCORD) Trial  
  Connie Kingry, RN, BSN, Arnaud Bastien, MD , Gillian Booth, MD, MSC , Therese S. Geraci, MSN, Brenda Kirpach, CCRA, Laura C Lovato, MS, Karen Margolis, MD, MPH, Yves ..., J.AmJCard, 1/18/2007
• Mitigating Cardiovascular Risks in Diabetes  
  Arnaud Bastien, MD, Practical Diabetology, 1/14/2007
• "Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic" The Antihypertensive a...  
  Arnaud Bastien MD, JAMA, 1/1/2002
• "Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care" The Antihypertensive and Lipid-Lowering Treatment to...  
  Arnaud Bastien MD, JAMA, 1/1/2002
• HIV in the Inner Cities: Epidemiologic Trends and their Influence on Policy Making Decisions  
  Arnaud Bastien, MD, Journal of Community Health, 1/1/1995
• The ACCORD Trial: A Multidisciplinary Approach to Control Cardiovascular Risk in Type 2 Diabetes Mellitus  
  The ACCORD Study Group, Practical Diabetology
• Join now to see all

Abstracts/Posters

• Management of High Blood Pressure in Clinical Practice: Perceptible Qualitative Differences in Approaches Utilized by Clinicians
  Arnaud Bastien MD, Michael Caso, Jeffrey A. Cutler MD, Barry R Davis MD PhD, Glenda Grob, Karen Margolis MD, Chuke Nwachuku MA MPH DrPH; Edward Rocella PhD; Sheldon Sh..., J. Clinical Hypertension, 1/1/2007
• Validity and Predictors of Adherence to Metformin In a Multiracial Clinical Trial
  Margolis, KL.; Hildebrant; Sereika, SM.; Bastien, A.; Lovato, JF.; Nwachuku, C, 2nd Scientific Conference on Compliance in Healthcare and Research; Circulation, Washington, DC, 1/17/2004
• Human Papilloma virus (HPV) Is More Common Among Younger Women with Cervical Ectopy or Coital Bleeding: A Report from the Heterosexual HIV Transmission Study
  Kelly, P; Vermund, SH; Bromberg, J; DeHovitz, JA; Bastien, A; Handte, J; Landesman ,SH; Burk, RD, VIII International Conference on AIDS, Amsterdam, Holland, 1/1/1992
• Retention in a Women's HIV Transmission Cohort: Combining Clinical Care with Health Education as a Strategy for Retention
  American Public Health Association Annual Meetings, Washington, DC, 1/1/1992
• Bastien, A.; DeHovitz, JA; Covino, JM; Smith B.; Landesman, SH; Stevens, R.; McCormack, W., VI International Conference on AIDS, San Francisco, CA, 1/1/1990
• A Model for cooperation Between an University Medical Center (UMC) and Community Based Operations (CBO's) Responding to HIV Disease
  Bastien, A; Freedman, P; Conde, A; Sinclair, L; DeHovitz, JA, VI International Conference on AIDS, San Francisco, CA, 1/1/1990
• Are Women at Risk More Likely to Seek Voluntary Testing Than Men?
  Bastien, A.; DeHovitz,lA; Smith,B;Covino,1M; Landesman,SH; Stevens, R.; McCormack, W., American Public Health Association Annual Meeting, New York, NY, 1/1/1990
• Implementing a culturally sensitive AIDS Prevention Program for Haitian Immigrants in New York
  Bastien, A.; Freedman, P.; Norat, Y.; DeHovitz, JA., AIDS: the Scientific and Social Challenge; V International Conference on AIDS, Montreal, Canada, 1/1/1989
• HIV Infection in Patients Attending a Hospital Based Sexually Transmitted Diseases Clinic
  DeHovitz, JA.; Freedman, P.; Bastien, A.; Norat, Y., AIDS: the Scientific and Social Challenge; V International Conference on AIDS, 1/1/1989
• Differences between Symptomatic HIV (+) Female and Male Patients
  Kelly, P.; Graham, V.; DeHovitz, JA.; Hall, L.; Kitchens, A.; Bastien, A., AIDS: the Scientific and Social Challenge; V International Conference on AIDS, 1/1/1989
• P. Kelly, S.H. Vermund; J. DeHovitz; J.; Bromberg; A. Bastien; J. Handle; S. Landesman; and R.D. Burk, Multiple presentations
• Join now to see all